Colorectal Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Colorectal Cancer, including details on symptoms, genetics, screening, treatment, information.

Volume 2 (2005), Issue 4 (April)

1. Radiofrequency ablation therapy of remnant colorectal liver metastases after a course of hepatic arterial infusion chemotherapy.
   J Vasc Interv Radiol, 16(4): 549-54. [Abstract] [Full-text]
2. Liposome-encapsulated prednisolone phosphate inhibits growth of established tumors in mice.
   Neoplasia, 7(2): 118-27. [Abstract] [Full-text]
3. Genetic and epigenetic changes of components affecting the WNT pathway in colorectal carcinomas stratified by microsatellite instability.
   Neoplasia, 7(2): 99-108. [Abstract] [Full-text]
4. Immunohistochemical expression of vascular endothelial growth factor and microvessel counting as prognostic indicators in node-negative colorectal cancer.
   Tumour Biol, 26(1): 1-8. [Abstract] [Full-text]
5. Genetic polymorphism in cytochrome P450 7A1 and risk of colorectal cancer: the Fukuoka Colorectal Cancer Study.
   Cancer Res, 65(7): 2979-82. [Abstract] [Full-text]
6. Eradication of tumors from a human colon cancer cell line and from ovarian cancer metastases in immunodeficient mice by a single-chain Ep-CAM-/CD3-bispecific antibody construct.
   Cancer Res, 65(7): 2882-9. [Abstract] [Full-text]
7. Cytoplasmic phospholipase A2 deletion enhances colon tumorigenesis.
   Cancer Res, 65(7): 2636-43. [Abstract] [Full-text]
8. Genetic and epigenetic alterations of the candidate tumor-suppressor gene MYO18B, on chromosome arm 22q, in colorectal cancer.
   Genes Chromosomes Cancer, 43(2): 162-71. [Abstract] [Full-text]
9. A substantial proportion of microsatellite-unstable colon tumors carry TP53 mutations while not showing chromosomal instability.
   Genes Chromosomes Cancer, 43(2): 194-201. [Abstract] [Full-text]
10. Lymph node metastases of prostatic adenocarcinoma in the mesorectum in patients with adenocarcinoma or villous tumor of the rectum with collision phenomenon in a single lymph node: report of five cases.
    Dis Colon Rectum, 48(2): 384-9. [Abstract] [Full-text]
11. Lymphatic staging in colorectal cancer: pathologic, molecular, and sentinel node techniques.
    Dis Colon Rectum, 48(2): 371-83. [Abstract] [Full-text]
12. Relationship between surgeon caseload and sphincter preservation in patients with rectal cancer.
    Dis Colon Rectum, 48(2): 195-202; discussion 202-4. [Abstract] [Full-text]
13. Meat consumption and K-ras mutations in sporadic colon and rectal cancer in The Netherlands Cohort Study.
    Br J Cancer, 92(7): 1310-20. [Abstract] [Full-text]
14. Non-steroidal anti-inflammatory drugs and colorectal cancer prevention.
    Postgrad Med J, 81(954): 223-7. [Abstract] [Full-text]
15. Cost implications of post-surgical morbidity following blood transfusion in cancer patients undergoing elective colorectal resection: an evaluation in the US hospital setting.
    Curr Med Res Opin, 21(3): 447-55. [Abstract] [Full-text]
16. Effective treatment of anal cancer in the elderly with low-dose chemoradiotherapy.
    Br J Cancer, 92(7): 1221-5. [Abstract] [Full-text]
17. Gene expression profiling of colorectal adenomas and early invasive carcinomas by cDNA array analysis.
    Br J Cancer, 92(7): 1193-200. [Abstract] [Full-text]
18. Preoperative short-term radiation therapy (25 Gy, 2.5 Gy twice daily) for primary resectable rectal cancer (phase II).
    Br J Cancer, 92(7): 1209-14. [Abstract] [Full-text]
19. Intensified concurrent chemoradiotherapy with 5-fluorouracil and irinotecan as neoadjuvant treatment in patients with locally advanced rectal cancer.
    Br J Cancer, 92(7): 1215-20. [Abstract] [Full-text]
20. Sequential treatment with irinotecan and doxifluridine: optimal dosing schedule in murine models and in a phase I study for metastatic colorectal cancer.
    Chemotherapy, 51(1): 32-9. [Abstract] [Full-text]
21. Indications of endoscopic polypectomy for rectal carcinoid tumors and clinical usefulness of endoscopic ultrasonography.
    Dis Colon Rectum, 48(2): 285-91. [Abstract] [Full-text]
22. Pelvic sepsis after extended Hartmann's procedure.
    Dis Colon Rectum, 48(2): 251-5. [Abstract] [Full-text]
23. Validity of pelvic autonomic nerve stimulation with intraoperative monitoring of bladder function following total mesorectal excision for rectal cancer.
    Dis Colon Rectum, 48(2): 262-9. [Abstract] [Full-text]
24. The human leukocyte antigen region and colorectal cancer risk.
    Dis Colon Rectum, 48(2): 303-6. [Abstract] [Full-text]
25. Prospective, randomized trial comparing intraoperative colonic irrigation with manual decompression only for obstructed left-sided colorectal cancer.
    Dis Colon Rectum, 48(2): 205-9. [Abstract] [Full-text]
26. Transanal endoscopic microsurgery: a systematic review.
    Dis Colon Rectum, 48(2): 270-84. [Abstract] [Full-text]
27. Proximal location of colon cancer is a risk factor for development of metachronous colorectal cancer: a population-based study.
    Dis Colon Rectum, 48(2): 227-32. [Abstract] [Full-text]
28. Outcome of anterior resection for stage II rectal cancer without radiation: the role of adjuvant chemotherapy.
    Dis Colon Rectum, 48(2): 218-26. [Abstract] [Full-text]
29. Denervation of the neorectum as a potential cause of defecatory disorder following low anterior resection for rectal cancer.
    Dis Colon Rectum, 48(2): 210-7. [Abstract] [Full-text]
30. Tumor budding as an indicator of isolated tumor cells in lymph nodes from patients with node-negative colorectal cancer.
    Dis Colon Rectum, 48(2): 292-302. [Abstract] [Full-text]
31. Primary malignant fibrous histiocytoma of the ascending colon: report of a case.
    Surg Today, 35(4): 323-7. [Abstract] [Full-text]
32. Repeat hepatectomy for recurrent colorectal metastases.
    Surg Today, 35(4): 282-9. [Abstract] [Full-text]
33. Surgical options for malignant left-sided colonic obstruction.
    Surg Today, 35(4): 275-81. [Abstract] [Full-text]
34. Advantage of a residualizing iodine radiolabel in the therapy of a colon cancer xenograft targeted with an anticarcinoembryonic antigen monoclonal antibody.
    Clin Cancer Res, 11(7): 2727-34. [Abstract] [Full-text]
35. Variance in the expression of 5-Fluorouracil pathway genes in colorectal cancer.
    Clin Cancer Res, 11(7): 2612-9. [Abstract] [Full-text]
36. SMAD4 as a prognostic marker in colorectal cancer.
    Clin Cancer Res, 11(7): 2606-11. [Abstract] [Full-text]
37. Prognostic value of tumor-infiltrating dendritic cells in colorectal cancer: role of maturation status and intratumoral localization.
    Clin Cancer Res, 11(7): 2576-82. [Abstract] [Full-text]
38. Colorectal cancer screening in Finland: details of the national screening programme implemented in Autumn 2004.
    J Med Screen, 12(1): 28-32. [Abstract] [Full-text]
39. Gender differences in utilization of colorectal cancer screening.
    J Med Screen, 12(1): 20-7. [Abstract] [Full-text]
40. Microsatellite instability of selective target genes in HNPCC-associated colon adenomas.
    Oncogene, 24(15): 2525-35. [Abstract] [Full-text]
41. The guanine nucleotide exchange factor Tiam1 increases colon carcinoma growth at metastatic sites in an orthotopic nude mouse model.
    Oncogene, 24(15): 2568-73. [Abstract] [Full-text]
42. Preclinical application of radioimmunoguided surgery using anti-carcinoembryonic antigen biparatopic antibody in the colon cancer.
    Eur Surg Res, 37(1): 36-44. [Abstract] [Full-text]
43. Preoperative chemoradiation with oral tegafur within a multidisciplinary therapeutic approach in patients with T3-4 rectal cancer.
    Int J Radiat Oncol Biol Phys, 61(5): 1378-84. [Abstract] [Full-text]
44. Preoperative radiotherapy for rectal adenocarcinoma: Which are strong prognostic factors?
    Int J Radiat Oncol Biol Phys, 61(5): 1371-7. [Abstract] [Full-text]
45. Survivin enhances telomerase activity via up-regulation of specificity protein 1- and c-Myc-mediated human telomerase reverse transcriptase gene transcription.
    Exp Cell Res, 305(2): 300-11. [Abstract] [Full-text]
46. Antitumor activity of albendazole against the human colorectal cancer cell line HT-29: in vitro and in a xenograft model of peritoneal carcinomatosis.
    Cancer Chemother Pharmacol, 55(5): 425-32. [Abstract] [Full-text]
47. T-cell lymphoma of the rectum in a patient with AIDS and hepatitis C: a case report and discussion.
    Oncologist, 10(4): 292-8. [Abstract] [Full-text]
48. Critical evaluation of current treatments in metastatic colorectal cancer.
    Oncologist, 10(4): 250-61. [Abstract] [Full-text]
49. Purification of cyclotron-produced 203Pb for labeling Herceptin.
    Nucl Med Biol, 32(3): 301-5. [Abstract] [Full-text]
50. Effects of black grape extract on activities of DNA turn-over enzymes in cancerous and non cancerous human colon tissues.
    Life Sci, 76(25): 2995-3000. [Abstract] [Full-text]
51. Wide local excision or abdominoperineal resection as the initial treatment for anorectal melanoma?
    Am J Surg, 189(4): 446-9. [Abstract] [Full-text]
52. A prospective study of outcomes of emergency and elective surgeries for complicated colonic cancer.
    Am J Surg, 189(4): 377-83. [Abstract] [Full-text]
53. Right- and left-sided colorectal cancers display distinct expression profiles and the anatomical stratification allows a high accuracy prediction of lymph node metastasis.
    J Surg Res, 124(2): 216-24. [Abstract] [Full-text]
54. Determination of operation time in colorectal diseases: preoperative chemotherapy application.
    J Surg Res, 124(2): 209-15. [Abstract] [Full-text]
55. Is it reasonable to add preoperative serum level of CEA and CA19-9 to staging for colorectal cancer?
    J Surg Res, 124(2): 169-74. [Abstract] [Full-text]
56. Increase in the frequency of K-ras codon 12 point mutation in colorectal carcinoma in elderly males in Japan: the 1990s compared with the 1960s.
    Cancer Sci, 96(4): 218-20. [Abstract] [Full-text]
57. The GADD45, ZBRK1 and BRCA1 pathway: quantitative analysis of mRNA expression in colon carcinomas.
    J Pathol, 206(1): 92-9. [Abstract] [Full-text]
58. Cell turnover of serrated adenomas.
    J Pathol, 206(1): 62-7. [Abstract] [Full-text]
59. Reported use of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors was not associated with reduced recurrence of colorectal adenomas.
    Cancer Epidemiol Biomarkers Prev, 14(4): 1026-7. [Abstract] [Full-text]
60. Levels of physical activity for colon cancer prevention compared with generic public health recommendations: population prevalence and sociodemographic correlates.
    Cancer Epidemiol Biomarkers Prev, 14(4): 1000-2. [Abstract] [Full-text]
61. APC Asp1822Val and Gly2502Ser polymorphisms and risk of colorectal cancer and adenoma.
    Cancer Epidemiol Biomarkers Prev, 14(4): 863-70. [Abstract] [Full-text]
62. Detection of alkaline sphingomyelinase activity in human stool: proposed role as a new diagnostic and prognostic marker of colorectal cancer.
    Cancer Epidemiol Biomarkers Prev, 14(4): 856-62. [Abstract] [Full-text]
63. A prospective study of C-peptide, insulin-like growth factor-I, insulin-like growth factor binding protein-1, and the risk of colorectal cancer in women.
    Cancer Epidemiol Biomarkers Prev, 14(4): 850-5. [Abstract] [Full-text]
64. Fiber intake and incidence of colorectal cancer among 76,947 women and 47,279 men.
    Cancer Epidemiol Biomarkers Prev, 14(4): 842-9. [Abstract] [Full-text]
65. Dietary marine n-3 fatty acids in relation to risk of distal colorectal adenoma in women.
    Cancer Epidemiol Biomarkers Prev, 14(4): 835-41. [Abstract] [Full-text]
66. Chemoprevention: mouse colon and lung tumor bioassay and modulation of DNA methylation as a biomarker.
    Exp Lung Res, 31(2): 145-63. [Abstract] [Full-text]
67. A longitudinal study of exercise barriers in colorectal cancer survivors participating in a randomized controlled trial.
    Ann Behav Med, 29(2): 147-53. [Abstract] [Full-text]
68. Possible participation of advanced glycation end products in the pathogenesis of colorectal cancer in diabetic patients.
    Med Hypotheses, 64(6): 1208-10. [Abstract] [Full-text]
69. Selenium supplementation may increase the efficacy of cetuximab in metastatic colorectal cancer patients.
    Med Hypotheses, 64(6): 1162-5. [Abstract] [Full-text]
70. Extrauterine müllerian adenosarcoma associated with endometriosis and rectal villotubular adenoma: report of a case and review of the literature.
    Int J Gynecol Cancer, 15(2): 361-5. [Abstract] [Full-text]
71. The role of the insulin-like growth factor system in colorectal cancer: review of current knowledge.
    Int J Colorectal Dis, 20(3): 203-20. [Abstract] [Full-text]
72. Microscopic spread of low rectal cancer in regions of the mesorectum: detailed pathological assessment with whole-mount sections.
    Int J Colorectal Dis, 20(3): 231-7. [Abstract] [Full-text]
73. Results of treatment of distal rectal carcinoma since the introduction of total mesorectal excision: a single unit experience, 1994-2003.
    Int J Colorectal Dis, 20(3): 221-30. [Abstract] [Full-text]
74. Increased plasma MMP-2 protein expression in lymph node-positive patients with colorectal cancer.
    Int J Colorectal Dis, 20(3): 245-52. [Abstract] [Full-text]
75. Serum laminin is an independent prognostic factor in colorectal cancer.
    Int J Colorectal Dis, 20(3): 238-44. [Abstract] [Full-text]
76. Adjuvant chemotherapy in curative resected colon carcinoma: 5-fluorouracil/leucovorin versus high-dose 5-fluorouracil 24-h infusion/leucovorin versus high-dose 5-fluorouracil 24-h infusion.
    Int J Colorectal Dis, 20(3): 258-61. [Abstract] [Full-text]
77. A case of colorectal carcinoma in adenoma analyzed by a cDNA array.
    Int J Colorectal Dis, 20(3): 287-91. [Abstract] [Full-text]
78. Isolated hepatic perfusion for the treatment of patients with colorectal cancer liver metastases after irinotecan-based therapy.
    Ann Surg Oncol, 12(2): 138-44. [Abstract] [Full-text]
79. Prospective evaluation of quality of life of patients receiving either abdominoperineal resection or sphincter-preserving procedure for rectal cancer.
    Ann Surg Oncol, 12(2): 117-23. [Abstract] [Full-text]
80. Relationship between pathologic T-stage and nodal metastasis after preoperative chemoradiotherapy for locally advanced rectal cancer.
    Ann Surg Oncol, 12(2): 111-6. [Abstract] [Full-text]
81. Rectus flap reconstruction decreases perineal wound complications after pelvic chemoradiation and surgery: a cohort study.
    Ann Surg Oncol, 12(2): 104-10. [Abstract] [Full-text]
82. Long-term survival of peritoneal carcinomatosis of colorectal origin.
    Ann Surg Oncol, 12(1): 65-71. [Abstract] [Full-text]
83. Structural and numerical chromosome changes in colon cancer develop through telomere-mediated anaphase bridges, not through mitotic multipolarity.
    Proc Natl Acad Sci U S A, 102(15): 5541-6. [Abstract] [Full-text]
84. Cancer, Medicaid enrollment, and survival disparities.
    Cancer, 103(8): 1712-8. [Abstract] [Full-text]
85. Bile acids induce MUC2 overexpression in human colon carcinoma cells.
    Cancer, 103(8): 1606-14. [Abstract] [Full-text]
86. Evaluation of an immunochemical fecal occult blood test with automated reading in screening for colorectal cancer in a general average-risk population.
    Int J Cancer, 115(3): 493-6. [Abstract] [Full-text]
87. Expression of IL-27 in murine carcinoma cells produces antitumor effects and induces protective immunity in inoculated host animals.
    Int J Cancer, 115(3): 437-42. [Abstract] [Full-text]
88. Diets, polymorphisms of methylenetetrahydrofolate reductase, and the susceptibility of colon cancer and rectal cancer.
    Cancer Detect Prev, 29(2): 146-54. [Abstract] [Full-text]
89. The long-term voiding function and sexual function after pelvic nerve-sparing radical surgery for rectal cancer.
    Int J Urol, 12(3): 256-63. [Abstract] [Full-text]
90. Expression and function of vascular endothelial growth factor receptor-1 on human colorectal cancer cells.
    Oncogene, 24(16): 2647-53. [Abstract] [Full-text]
91. Placenta growth factor expression is correlated with survival of patients with colorectal cancer.
    Gut, 54(5): 666-72. [Abstract] [Full-text]
92. Impaired CD95 expression predisposes for recurrence in curatively resected colon carcinoma: clinical evidence for immunoselection and CD95L mediated control of minimal residual disease.
    Gut, 54(5): 661-5. [Abstract] [Full-text]
93. Increased microvascular blood content is an early event in colon carcinogenesis.
    Gut, 54(5): 654-60. [Abstract] [Full-text]
94. Effect of folic acid supplementation on genomic DNA methylation in patients with colorectal adenoma.
    Gut, 54(5): 648-53. [Abstract] [Full-text]
95. The C/C-13910 genotype of adult-type hypolactasia is associated with an increased risk of colorectal cancer in the Finnish population.
    Gut, 54(5): 643-7. [Abstract] [Full-text]
96. Association between family history and mismatch repair in colorectal cancer.
    Gut, 54(5): 636-42. [Abstract] [Full-text]
97. Associations in breast and colon cancer screening behavior in women.
    Acad Radiol, 12(4): 451-8. [Abstract] [Full-text]
98. Wnt signaling in the intestinal epithelium: from endoderm to cancer.
    Genes Dev, 19(8): 877-90. [Abstract] [Full-text]
99. Magnetic resonance spectroscopy monitoring of mitogen-activated protein kinase signaling inhibition.
    Cancer Res, 65(8): 3356-63. [Abstract] [Full-text]
100. Down-regulation of mitochondrial F1F0-ATP synthase in human colon cancer cells with induced 5-fluorouracil resistance.
     Cancer Res, 65(8): 3162-70. [Abstract] [Full-text]
101. COX-2: a molecular target for colorectal cancer prevention.
     J Clin Oncol, 23(12): 2840-55. [Abstract] [Full-text]
102. Chemokine receptor CXCR4 expression in colorectal cancer patients increases the risk for recurrence and for poor survival.
     J Clin Oncol, 23(12): 2744-53. [Abstract] [Full-text]
103. Phase I study of immunization with dendritic cells modified with fowlpox encoding carcinoembryonic antigen and costimulatory molecules.
     Clin Cancer Res, 11(8): 3017-24. [Abstract] [Full-text]
104. N(1),N(12)-Diacetylspermine as a sensitive and specific novel marker for early- and late-stage colorectal and breast cancers.
     Clin Cancer Res, 11(8): 2986-90. [Abstract] [Full-text]
105. Clinical significance of human kallikrein gene 6 messenger RNA expression in colorectal cancer.
     Clin Cancer Res, 11(8): 2889-93. [Abstract] [Full-text]
106. Colorectal papillomavirus infection in patients with colorectal cancer.
     Clin Cancer Res, 11(8): 2862-7. [Abstract] [Full-text]
107. Changes over time in thymidine phosphorylase and dihydropyrimidine dehydrogenase when colon cancer samples are left at room temperature.
     Cancer Lett, 222(1): 107-12. [Abstract] [Full-text]
108. Identification of sentinel nodes in patients with colon cancer.
     Eur J Surg Oncol, 31(4): 381-5. [Abstract] [Full-text]
109. Clinical significance of enhancer of zeste homolog 2 expression in colorectal cancer cases.
     Eur J Surg Oncol, 31(4): 376-80. [Abstract] [Full-text]
110. The use of irinotecan and oxaliplatin in the treatment of advanced colorectal cancer.
     Eur J Surg Oncol, 31(4): 325-30. [Abstract] [Full-text]
111. Evidence for genetic anticipation in hereditary non-polyposis colorectal cancer.
     Hum Genet, 116(6): 461-5. [Abstract] [Full-text]
112. Cyclooxygenase-2 regulation in colon cancer cells: modulation of RNA polymerase II elongation by histone deacetylase inhibitors.
     J Biol Chem, 280(16): 15503-9. [Abstract] [Full-text]
113. T-cell receptor BV gene usage in colorectal carcinoma patients immunised with recombinant Ep-CAM protein or anti-idiotypic antibody.
     Cancer Immunol Immunother, 54(6): 557-70. [Abstract] [Full-text]
114. Cigarette smoking and colorectal cancer: APC mutations, hMLH1 expression, and GSTM1 and GSTT1 polymorphisms.
     Am J Epidemiol, 161(9): 806-15. [Abstract] [Full-text]
115. Ileocolonic lymphomas: a series of 16 cases.
     Endoscopy, 37(5): 466-9. [Abstract] [Full-text]
116. Immunobead multiplex RT-PCR detection of carcinoembryonic genes expressing cells in the blood of colorectal cancer patients.
     Clin Chem Lab Med, 43(2): 127-32. [Abstract] [Full-text]
117. Treatment of stage IV colorectal carcinoma in elderly patients.
     Crit Rev Oncol Hematol, 54(2): 145-55. [Abstract] [Full-text]
118. Characterization of macrophage subpopulations in colon cancer using tissue microarrays.
     Histopathology, 46(5): 515-21. [Abstract] [Full-text]
119. Human papillomavirus anogenital disease in HIV-infected individuals.
     Dermatol Ther, 18(1): 67-76. [Abstract] [Full-text]
120. Risk of colorectal neoplasm in patients with acromegaly and its relationship with serum growth hormone levels.
     Am J Gastroenterol, 100(5): 1154-60. [Abstract] [Full-text]
121. Adenomas in young patients: what is the optimal evaluation?
     Am J Gastroenterol, 100(5): 1150-3. [Abstract] [Full-text]
122. Low rate of microsatellite instability in young patients with adenomas: reassessing the Bethesda guidelines.
     Am J Gastroenterol, 100(5): 1143-9. [Abstract] [Full-text]
123. Differences in attitudes between patients with primary colorectal cancer and patients with secondary colorectal cancer: is it reflected in their willingness to participate in drug trials?
     Eur J Cancer Care (Engl), 14(2): 166-70. [Abstract] [Full-text]
124. Randomized crossover trial of intravenous 5-FU versus oral UFT both modulated by leucovorin: a one-centre experience.
     Eur J Cancer Care (Engl), 14(2): 151-4. [Abstract] [Full-text]
125. Eliciting relative preferences for two methods of colorectal cancer screening.
     Eur J Cancer Care (Engl), 14(2): 124-31. [Abstract] [Full-text]
126. Oxaliplatin combined with irinotecan and 5-fluorouracil/leucovorin (OCFL) in metastatic colorectal cancer: a phase I-II study.
     Ann Oncol, 16(5): 762-6. [Abstract] [Full-text]
127. Adjuvant treatment for elderly patients with stage III colon cancer in the southern Netherlands is affected by socioeconomic status, gender, and comorbidity.
     Ann Oncol, 16(5): 767-72. [Abstract] [Full-text]
128. Time trends in the treatment and survival of recurrences from colorectal cancer.
     Ann Oncol, 16(5): 756-61. [Abstract] [Full-text]
129. Successful desensitization to oxaliplatin.
     Ann Pharmacother, 39(5): 966-9. [Abstract] [Full-text]
130. Interleukin-4 gene transduced tumor cells promote a potent tumor-specific Th1-type response in cooperation with interferon-alpha transduction.
     Gene Ther, 12(9): 733-41. [Abstract] [Full-text]
131. Colorectal cancer in two pre-teenage siblings with familial adenomatous polyposis.
     Eur J Pediatr, 164(5): 306-10. [Abstract] [Full-text]
132. Quality of life after rectal resection for cancer, with or without permanent colostomy.
     Cochrane Database Syst Rev. [Abstract] [Full-text]
133. Phase II study of irinotecan, 5-fluorouracil and leucovorin as first-line therapy for advanced colorectal cancer.
     Jpn J Clin Oncol, 35(4): 214-7. [Abstract] [Full-text]
134. Evaluation of the use of computed tomography versus conventional orthogonal X-ray simulation in the treatment of rectal cancer.
     Australas Radiol, 49(2): 122-6. [Abstract] [Full-text]
135. Gastrin stabilises beta-catenin protein in mouse colorectal cancer cells.
     Br J Cancer, 92(8): 1581-7. [Abstract] [Full-text]
136. Combined inhibition of extracellular signal-regulated kinases and HSP90 sensitizes human colon carcinoma cells to ionizing radiation.
     Oncogene, 24(18): 3011-9. [Abstract] [Full-text]
137. Blockade of Wnt-1 signaling induces apoptosis in human colorectal cancer cells containing downstream mutations.
     Oncogene, 24(18): 3054-8. [Abstract] [Full-text]
138. Quality of treatment in routine care in a population sample of rectal cancer patients.
     Acta Oncol, 44(1): 65-74. [Abstract] [Full-text]
139. De novo colorectal cancer: five-year survival is markedly lower in transplant recipients compared with the general population.
     Transplant Proc, 37(2): 960-1. [Abstract] [Full-text]
140. Pharmacology of oxaliplatin and the use of pharmacogenomics to individualize therapy.
     Cancer Treat Rev, 31(2): 90-105. [Abstract] [Full-text]
141. Oxaliplatin-induced immune pancytopenia.
     Transfusion, 45(5): 704-8. [Abstract] [Full-text]
142. Periostin induction in tumor cell line explants and inhibition of in vitro cell growth by anti-periostin antibodies.
     Carcinogenesis, 26(5): 908-15. [Abstract] [Full-text]
143. Evolution of intratumoral genetic heterogeneity during colorectal cancer progression.
     Carcinogenesis, 26(5): 916-22. [Abstract] [Full-text]
144. Absence of acute apoptotic response to genotoxic carcinogens in p53-deficient mice is associated with increased susceptibility to azoxymethane-induced colon tumours.
     Int J Cancer, 115(4): 561-7. [Abstract] [Full-text]
145. Prospective study of N-acetyltransferase-2 genotypes, meat intake, smoking and risk of colorectal cancer.
     Int J Cancer, 115(4): 648-52. [Abstract] [Full-text]
146. Association of Ets-related transcriptional factor E1AF expression with overexpression of matrix metalloproteinases, COX-2 and iNOS in the early stage of colorectal carcinogenesis.
     Carcinogenesis, 26(5): 892-9. [Abstract] [Full-text]
147. Casein kinase 2- and protein kinase A-regulated adenomatous polyposis coli and beta-catenin cellular localization is dependent on p38 MAPK.
     J Biol Chem, 280(17): 17221-6. [Abstract] [Full-text]
148. Preoperative staging of rectal cancer by MRI; results of a UK survey.
     Clin Radiol, 60(5): 579-86. [Abstract] [Full-text]
149. National audit of the sensitivity of double-contrast barium enema for colorectal carcinoma, using control charts For the Royal College of Radiologists Clinical Radiology Audit Sub-Committee.
     Clin Radiol, 60(5): 558-64. [Abstract] [Full-text]
150. Men's experiences of physical exams and cancer screening tests: a qualitative study.
     Prev Med, 40(6): 628-35. [Abstract] [Full-text]
151. Testing a culturally appropriate, theory-based intervention to improve colorectal cancer screening among Native Hawaiians.
     Prev Med, 40(6): 619-27. [Abstract] [Full-text]
152. Imaging of single human carcinoma cells in vitro using a clinical whole-body magnetic resonance scanner at 3.0 T.
     Magn Reson Med, 53(5): 1187-92. [Abstract] [Full-text]
153. Accuracy of revised Bethesda guidelines, microsatellite instability, and immunohistochemistry for the identification of patients with hereditary nonpolyposis colorectal cancer.
     JAMA, 293(16): 1986-94. [Abstract] [Full-text]
154. Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X.
     JAMA, 293(16): 1979-85. [Abstract] [Full-text]
155. Clinical significance of microsatellite instability in the inflamed mucosa for the prediction of colonic neoplasms in patients with ulcerative colitis.
     J Gastroenterol Hepatol, 20(5): 710-5. [Abstract] [Full-text]
156. Risk of colorectal cancer in ulcerative colitis in India.
     J Gastroenterol Hepatol, 20(5): 705-9. [Abstract] [Full-text]
157. Allogeneic dendritomas induce anti-tumour immunity against metastatic colon cancer.
     Scand J Immunol, 61(4): 364-9. [Abstract] [Full-text]
158. G protein-coupled lysophosphatidic acid receptors stimulate proliferation of colon cancer cells through the {beta}-catenin pathway.
     Proc Natl Acad Sci U S A, 102(17): 6027-32. [Abstract] [Full-text]
159. Empirical Bayes screening of many p-values with applications to microarray studies.
     Bioinformatics, 21(9): 1987-94. [Abstract] [Full-text]
160. Robust estimation of protein expression ratios with lysate microarray technology.
     Bioinformatics, 21(9): 1935-42. [Abstract] [Full-text]
161. 5-Fluorouracil/irinotecan induced lethal toxicity as a result of a combined pharmacogenetic syndrome: report of a case.
     J Clin Pathol, 58(5): 553-5. [Abstract] [Full-text]
162. Expression of secreted Wnt antagonists in gastrointestinal tissues: potential role in stem cell homeostasis.
     J Clin Pathol, 58(5): 515-9. [Abstract] [Full-text]
163. Expression and gene amplification of primary (A, B1, D1, D3, and E) and secondary (C and H) cyclins in colon adenocarcinomas and correlation with patient outcome.
     J Clin Pathol, 58(5): 509-14. [Abstract] [Full-text]
164. Predictive testing for hereditary nonpolyposis colorectal cancer: subjective perception regarding colorectal and endometrial cancer, distress, and health-related behavior at one year post-test.
     Genet Test, 9(1): 54-65. [Abstract] [Full-text]
165. APC germ-line mutations in southern Spanish patients with familial adenomatous polyposis: genotype-phenotype correlations and identification of eight novel mutations.
     Genet Test, 9(1): 37-40. [Abstract] [Full-text]
166. False-negative results at multi-detector row CT colonography: multivariate analysis of causes for missed lesions.
     Radiology, 235(2): 495-502. [Abstract] [Full-text]
167. Identifying target populations for screening or not screening using logic regression.
     Stat Med, 24(9): 1321-38. [Abstract] [Full-text]
168. Capecitabine as first-line treatment for patients older than 70 years with metastatic colorectal cancer: an oncopaz cooperative group study.
     J Clin Oncol, 23(13): 3104-11. [Abstract] [Full-text]
169. Catalytic subunit of human telomerase reverse transcriptase is an independent predictor of survival in patients undergoing curative resection of hepatic colorectal metastases: a multicenter analysis.
     J Clin Oncol, 23(13): 3086-93. [Abstract] [Full-text]
170. TGFBR1*6A may contribute to hereditary colorectal cancer.
     J Clin Oncol, 23(13): 3074-8. [Abstract] [Full-text]
171. Array-based analysis of genomic DNA methylation patterns of the tumour suppressor gene p16INK4A promoter in colon carcinoma cell lines.
     Nucleic Acids Res, 33(8): e73. [Abstract] [Full-text]
172. Exploring the decision-making preferences of people with colorectal cancer.
     Health Expect, 8(2): 103-13. [Abstract] [Full-text]
173. Unreasonable expectations in emergency colorectal cancer surgery.
     Colorectal Dis, 7(3): 275-8. [Abstract] [Full-text]
174. Colorectal cancer audit: a comparative study before and after establishing a specialty colorectal surgery unit.
     Colorectal Dis, 7(3): 270-4. [Abstract] [Full-text]
175. Variations in the evaluation of colorectal cancer risk.
     Colorectal Dis, 7(3): 254-62. [Abstract] [Full-text]
176. Bowel function following insertion of self-expanding metallic stents for palliation of colorectal cancer.
     Colorectal Dis, 7(3): 251-3. [Abstract] [Full-text]
177. Fast-track barium enema: meeting the two-week wait rule for patients with suspected colorectal cancer.
     Colorectal Dis, 7(3): 241-4. [Abstract] [Full-text]
178. MRI assessment of the bony pelvis may help predict resectability of rectal cancer.
     Colorectal Dis, 7(3): 232-40. [Abstract] [Full-text]
179. The role of prophylactic oophorectomy in women undergoing surgery for colorectal cancer.
     Colorectal Dis, 7(3): 214-7. [Abstract] [Full-text]
180. A meta-analysis of the association of physical activity with reduced risk of colorectal cancer.
     Colorectal Dis, 7(3): 204-13. [Abstract] [Full-text]
181. Reduced expression of Hugl-1, the human homologue of Drosophila tumour suppressor gene lgl, contributes to progression of colorectal cancer.
     Oncogene, 24(19): 3100-9. [Abstract] [Full-text]

© 2004-2008 Colorectal Cancer Research Today. All Rights Reserved.